| PACAP38 induces migraine-like attacks in patients with migraine without aura HW Schytz, S Birk, T Wienecke, C Kruuse, J Olesen, M Ashina Brain 132 (1), 16-25, 2009 | 508 | 2009 |
| A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks LL Thomsen, C Kruuse, HK Iversen, J Olesen European journal of neurology 1 (1), 73-80, 1994 | 368 | 1994 |
| Migraine can be induced by sildenafil without changes in middle cerebral artery diameter C Kruuse, LL Thomsen, S Birk, J Olesen Brain 126 (1), 241-247, 2003 | 350 | 2003 |
| The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers KA Petersen, S Birk, LH Lassen, C Kruuse, O Jonassen, L Lesko, ... Cephalalgia 25 (2), 139-147, 2005 | 211 | 2005 |
| Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a … PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ... The Lancet 391 (10123), 850-859, 2018 | 198 | 2018 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 194 | 2018 |
| Recurrent ischemic stroke–a systematic review and meta-analysis M Kolmos, L Christoffersen, C Kruuse Journal of Stroke and Cerebrovascular Diseases 30 (8), 105935, 2021 | 177 | 2021 |
| Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2012 L Bendtsen, S Birk, H Kasch, K Aegidius, PS Sørensen, LL Thomsen, ... The journal of headache and pain 13, 1-29, 2012 | 138 | 2012 |
| Effect of home-based high-intensity interval training in patients with lacunar stroke: a randomized controlled trial R Steen Krawcyk, A Vinther, NC Petersen, J Faber, HK Iversen, ... Frontiers in neurology 10, 664, 2019 | 135 | 2019 |
| The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects C Kruuse, LL Thomsen, TB Jacobsen, J Olesen Journal of Cerebral Blood Flow & Metabolism 22 (9), 1124-1131, 2002 | 132 | 2002 |
| The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers S Birk, JT Sitarz, KA Petersen, PS Oturai, C Kruuse, J Fahrenkrug, ... Regulatory peptides 140 (3), 185-191, 2007 | 105 | 2007 |
| The headache-inducing effect of cilostazol in human volunteers S Birk, C Kruuse, KA Petersen, P Tfelt-Hansen, J Olesen Cephalalgia 26 (11), 1304-1309, 2006 | 83 | 2006 |
| The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow S Birk, C Kruuse, KA Petersen, O Jonassen, P Tfelt-Hansen, J Olesen Journal of Cerebral Blood Flow & Metabolism 24 (12), 1352-1358, 2004 | 80 | 2004 |
| Endothelial function in migraine with aura–a systematic review JH Butt, U Franzmann, C Kruuse Headache: The Journal of Head and Face Pain 55 (1), 35-54, 2015 | 73 | 2015 |
| Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries S Birk, L Edvinsson, J Olesen, C Kruuse European journal of pharmacology 489 (1-2), 93-100, 2004 | 65 | 2004 |
| The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation C Kruuse, SD Rybalkin, TS Khurana, I Jansen-Olesen, J Olesen, ... European journal of pharmacology 420 (1), 55-65, 2001 | 65 | 2001 |
| The impact of aerobic and resistance training intensity on markers of neuroplasticity in health and disease T Hortobágyi, T Vetrovsky, GM Balbim, NCBS Silva, A Manca, F Deriu, ... Ageing Research Reviews 80, 101698, 2022 | 59 | 2022 |
| Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE)–study protocol for a randomised controlled trial P Kelly, C Weimar, R Lemmens, S Murphy, F Purroy, A Arsovska, ... European stroke journal 6 (2), 222-228, 2021 | 57 | 2021 |
| Neuroprotective mechanisms of glucagon‐like Peptide‐1‐based therapies in ischaemic stroke: a systematic review based on pre‐clinical studies IR Marlet, JNE Ölmestig, T Vilsbøll, J Rungby, C Kruuse Basic & clinical pharmacology & toxicology 122 (6), 559-569, 2018 | 54 | 2018 |
| Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: a systematic review of preclinical studies JNE Ölmestig, IR Marlet, AH Hainsworth, C Kruuse Cellular Signalling 38, 39-48, 2017 | 54 | 2017 |
Hannes Römer, Hannes RoemerDLRVerified email at arcor.de
